Decreasing malathion application time for lice treatment reduces transdermal absorption.

Area of Science:

• Dermatology
• Parasitology
• Toxicology

Background:

• Head lice infestations are common in the U.S., treated with topical pediculicides like Ovide (0.5% malathion).
• Current Ovide application requires 8-12 hours, despite malathion's rapid efficacy against lice and nits within 10 minutes.
• Concerns exist regarding excessive malathion exposure in children with prolonged application times.

Purpose of the Study:

• To investigate if reducing malathion application time decreases transdermal absorption.
• To compare malathion penetration and retention after 0.5-hour versus 8-hour topical application.

Main Methods:

• In vitro skin absorption studies were conducted using haired rat skin and human abdominal skin.
• Malathion penetration and residual amounts in the skin were quantified after washing post-application.

Main Results:

• A 0.5-hour malathion exposure resulted in significantly lower skin penetration (0.36%) and retention (2.1%) compared to an 8-hour exposure.
• The 8-hour application led to approximately three-fold greater penetration (1.02%) and retention (3.4%) in human skin (p<0.05).
• Similar absorption patterns were observed in rat skin, with absorption differences persisting for up to 72 hours.

Conclusions:

• A shortened 0.5-hour application of Ovide significantly reduces malathion skin penetration and retention compared to the standard 8-hour duration.
• This shorter duration appears to maintain efficacy, offering a potentially safer alternative for treating head lice.
• Further clinical trials in children are recommended to validate the efficacy of the reduced application time.